Alyeska Investment Group’s SELLAS Life Sciences SLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Hold |
0
| – | – | – | 660 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 626 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 581 |
|
|
2023
Q4 | – | Sell |
-640,011
| Closed | -$1.05M | – | 595 |
|
|
2023
Q3 | $1.05M | Sell |
640,011
-609,989
| -49% | -$1M | 0.01% | 402 |
|
|
2023
Q2 | $1.96M | Hold |
1,250,000
| – | – | 0.01% | 386 |
|
|
2023
Q1 | $1.79M | Buy |
+1,250,000
| New | +$1.79M | 0.02% | 343 |
|
|
2022
Q3 | – | Sell |
-254,018
| Closed | -$566K | – | 474 |
|
|
2022
Q2 | $566K | Buy |
+254,018
| New | +$566K | 0.01% | 522 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 436 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 451 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 446 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 476 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 406 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 415 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 464 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 478 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 474 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 479 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 496 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 515 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 527 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 515 |
|